Medpace Holdings (MEDP) Change in Receivables (2015 - 2026)

Medpace Holdings has reported Change in Receivables for 12 years, with the latest figure at -$7.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 478.06% year-over-year to -$7.8 million; the trailing twelve-month figure through Mar 2026 stood at $96.3 million (up 408.49% YoY), and the FY2025 full-year result was $106.2 million, up 4837.51% from the prior year.
• Change in Receivables for Q1 2026 stood at -$7.8 million, down from $29.1 million in the prior quarter.
• The five-year high for Change in Receivables was $79.9 million in Q2 2025, with the low at -$19.1 million in Q1 2024.
• Historically, Change in Receivables has averaged $12.4 million across 5 years, with a median of $9.0 million in 2023.
• Annual changes were most pronounced in 2022 — Change in Receivables jumped 7103.12% — and 2024, when it slumped 540.06%.
• Medpace Holdings' Change in Receivables stood at $4.5 million in 2022, then surged by 100.09% to $9.0 million in 2023, then tumbled by 270.32% to -$15.3 million in 2024, then soared by 290.49% to $29.1 million in 2025, then tumbled by 126.88% to -$7.8 million in 2026.
• The last three Change in Receivables figures came in at -$7.8 million (Q1 2026), $29.1 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.